Supplementary Table 6 from HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
Year: 2026
Type: supplementary-materials
Abstract: List of 568 proteins elevated in tumor tissues from lenvatinib non-responders compared with responders. (Log2 FC > 1, P-value < 0.05)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W7204999942
